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Abstract
Objectives
There have been no published recommendations about
staffing needs for a heart failure (HF) clinic or an office
setting focused on heart transplant. The goal of this survey
was to understand the current staffing environment of HF,
transplant, and mechanical circulatory support device
(MCSD) programs in the United States and abroad. This
The findings and conclusions in this report are those of the writing committee and do
not necessarily reflect the official position of the American College of Cardiology
Foundation, the American Heart Association, and the Heart Failure Society of
America.
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failure programs, including programs that perform heart transplant and mechanical
circulatory support device implantation: a report of the ACCF Heart Failure and
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Copies: This document is available on the World Wide Web sites of the American
College of Cardiology (www.cardiosource.org), the American Heart Association (my.
americanheart.org), and the Heart Failure Society of America (www.hfsa.org). For
copies of this document, please contact Elsevier Inc. Reprint Department, fax (212)
633-3820, e-mail reprints@elsevier.com.
Permissions: Multiple copies, modification, alteration, enhancement, and/or dis-
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endorse a particular staffing model.
Methods
An online survey, jointly sponsored by the American Col-
lege of Cardiology Foundation (ACCF), American Heart
Association (AHA), and the Heart Failure Society of
America (HFSA), was sent to the members of all 3
organizations who had identified themselves as interested in
HF, heart transplant, or both, between March 12, 2009, and
May 12, 2009.
Results
The overall response rate to the 1,823 e-mail surveys was
23%. There were 257 unique practices in the United States
(81% of total sites) and 58 international sites (19%);
approximately 30% of centers were in a cardiovascular group
practice and 30% in a medical school hospital setting. The
large majority of practices delivered HF care in both an
inpatient and outpatient environment, and slightly more
centers were implanting MCSDs (47%) than performing
cardiac transplantation (39%). Most practices (43%) were
small, with 4 staff members, or small- to medium-sized
(34%), with 4 to 10 staff members, with only 23% being
medium (11–20 staff) or large programs (20 staff). On
average, a U.S. HF practice cared for 1,641 outpatients
annually. An average HF program with transplant per-
formed 10 transplants. Although larger programs were able
to perform more transplants and see more outpatient HF
visits, their clinician staffing volume tended to double for
approximately every 500 to 700 additional HF visits annu-
ally. The average staffing utilization was 2.65 physician
full-time equivalents (FTEs), 2.21 nonphysician practitio-
ner (nurse practitioner or physician assistant) FTEs, and
2.61 nurse coordinator FTEs annually.
Conclusions
The HF patient population is growing in number in the
United States and internationally, and the clinicians who
provide the highly skilled and time-consuming care to this
population are under intense scrutiny as a result of focused
quality improvement initiatives and reduced financial re-
sources. Staffing guidelines should be developed to ensure
that an adequate number of qualified professionals are hired
for a given practice volume. These survey results are an
initial step in developing such standards.
1. Introduction
One in 8 deaths in the United States has HF listed on the
death certificate. The 2010 statistics from the AHA list HF
as one of the leading causes of hospitalization and death in
the United States and throughout Europe. Moreover, the
estimated direct and indirect cost of HF in the United
States for 2010 was $39.2 billion (1). To deliver more
specialized care to this patient population with unacceptablyhigh morbidity and mortality rates, the healthcare commu-
nity has responded by developing HF programs in both the
inpatient and outpatient setting (2). Practice guidelines have
been developed so that more standardized, evidence-based
care is available to all patients (3,4). In addition, third-party
payers and governmental agencies are increasingly monitor-
ing the quality and outcomes of care, the number of hospital
readmissions for HF, and the process of care in HF,
transplant, and MCSD programs (5–8). More recently,
standards have been published describing the necessary
components to achieve training and clinical competence in
the care of these patients (9). Mandatory governmental
review of U.S. transplant and MCSD programs has been in
place for years. Finally, the HFSA has published a consen-
sus statement that identifies the components of an outpa-
tient HF clinic most likely to contribute to the consistent
application of the guidelines and optimal patient care (10).
Despite the above-described efforts, individual programs
often struggle to find and retain qualified personnel willing
to make a full-time commitment to the delivery of care to
this complicated patient population. Complex decision
making and clinical acumen are necessary to manage an
advanced HF patient, and still more specialized knowledge
is required to care for the patient following heart transplan-
tation or implantation of an MCSD (11–15). However,
there have been no published recommendations about
staffing needs for an HF clinic or an office setting focused on
heart transplantation or MCSD placement. Therefore, our
goal with this survey was to understand the current staffing
environment of HF, transplant, and MCSD programs in
both the United States and abroad.
2. Methods
This 50-item survey was a jointly sponsored effort of the
ACCF, AHA, and HFSA. An online survey request (Sur-
vey Instrument available online with this article), signed by
the president of each organization, was sent to the members
of these organizations who had identified themselves as
interested in HF, heart transplant, or both. The survey was
live from March 12, 2009, to May 12, 2009, for ACC and
HFSA members and from March 16, 2009, to May 12,
2009, for AHA members. It was possible for an individual
to receive duplicate e-mails about the survey if he or she
belonged to more than one of the organizations.
A reminder was sent to ACC and HFSA members on
March 19, 2009, and again on April 14, 2009. AHA
members received additional reminders on March 23, 2009,
and April 14, 2009. Unique identifiers of each program were
ascertained, so that duplicate information was not collected.
If 1 staff member responded to the survey from an
individual site, the responses were averaged for that site.
When the results of the survey were analyzed, we thought
it would be useful to characterize the practices into
different-sized staffing groups. Thus, all data were grouped
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nurses, and other professional staff. Staff size does not
include nonclinical administrative assistants, secretaries,
laboratory technicians, or information specialists, however
much these staff members may be useful to individual
programs.
A writing group consisting of representatives from
ACCF, AHA, and HFSA was formed to analyze and report
survey results. Disclosure information showing authors’
relevant relationships with industry to this document is
included in Appendix 1. Appendix 2 lists peer reviewers for
this document, their affiliation in the review process, and
relationships with industry relevant to this topic.
3. Results
The overall response rate to the 1,823 e-mail invitations to
participate in the survey was 23%. From the ACCF mem-
bers, 125 (28%) respondents replied to a total of 450
invitations; the HFSA had 200 (32%) respondents of 616
survey invitations, and the AHA had 90 (12%) respondents
to 757 requests. After adjudication of duplicate site re-
sponses, there were 257 unique practices in the United
States (81% of total sites) and 58 international sites (19%)
from which the results were derived. As one measure of the
overall validity of our results, we calculated that 2,210 heart
transplants were performed in the United States in 2007 and
2,192 transplants in 2006. Assuming the accuracy of the
centers’ self-reporting of their annual transplant numbers,
these survey results represent approximately 88% to 90% of
the programs performing transplants in the United States
(see Table 1).
Although 19% of respondents were from centers outside
the United States, in general, these sites were smaller and
had a more narrow diversity of professional roles within
their centers; advanced practice nurses, social workers, and
pharmacists were less likely to be employed. Most of these
centers felt compelled to make an observation about their
smaller staff sizes compared with their perceptions of U.S.
programs. Our international respondents included Japan,
Canada, Spain, the Netherlands, Indonesia, Greece, Aus-
tralia, and China to name just a few. However, there were
no major differences when the international centers’ data
Table 1. U.S. Average Program Volume
Total
Small Program
(<4 staff)
n107
Destination MCSDs implanted per year 4.59 0.32
Heart transplants in 2007 10.31 1.17
Heart transplants in 2006 10.20 0.92
Heart transplants in 2005 9.85 1.06
Note: Data are grouped according to the number of clinical staff (i.e., physicians, nurses, and o
laboratory technicians, or information specialists.
MCSDs indicates mechanical circulatory support devices.were combined with the U.S. data compared with the U.S.data alone. We did not make statistical comparisons of the
international centers’ responses against the U.S. results.
Interestingly, 67% of the respondents identified them-
selves as physicians, 20% as nurse practitioners, and 3% as
nurses or nurse specialists. Nurses or clinical nurse special-
ists each accounted for 3% of the overall response, whereas
pharmacologists, physician assistants, and practice admin-
istrators each represented 1% of respondents. The remain-
ing 4% of respondents classified themselves as “other.”
Irrespective of the professional role of the clinician who
completed the survey, there were an overwhelming number
of additional comments on the majority of the completed
responses. The survey appeared to elicit impassioned de-
scriptions about the complicated nature of most of the
patients treated in these settings, and many voiced a need
for “more help”; many comments included a paraphrase of
“We are grossly understaffed!” Budgetary constraints on
expansion of services were likewise a major recurring theme
in the comments section.
4. Types of Practice Settings
Table 2 depicts a general description of the types of practice
settings. Cardiovascular group practices or a medical
school–affiliated practice were the most common settings,
each representing about a third of centers. The remainder of
respondents practiced in hospitals or other practice settings.
Each center chose from a variety of possible answers to the
question: “Does your practice have any or do any of the
following?” Most centers had both an inpatient and outpa-
tient HF service, and almost half were implanting MCSDs.
Approximately 40% of centers had a heart transplant pro-
gram. The survey also asked centers to choose the single best
answer to: “When patients with HF are hospitalized for
acute decompensation, who takes care of them at your
primary hospital?” A quarter of the centers had HF cardi-
ologists following these types of patients in hospital, and
another 40% had general cardiologists performing this duty.
5. Practice Clinical Volume
For most of the analyses, centers were divided into small
Small-Medium Program
(4–10 staff)
n86
Medium Program
(11–20 staff)
n45
Large Program
(>20 staff)
n14
4.88 10.07 9.26
8.94 18.42 41.75
8.35 18.34 43.85
8.20 17.95 40.18
ofessional staff). Staff size does not include nonclinical administrative assistants, secretaries,ther prpractices, with a staff size of 4 clinicians, small to medium
PS
P
P
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with 11 to 20 clinicians, and large centers, with 20
clinicians (Table 2). The majority of practices were small,
and only 8% of practices were classified as large. Table 1
shows an analysis of procedures performed according to
Table 2. U.S. and International Practice Descriptors
Descriptor %
rimary Practice Setting
Cardiovascular group 28
Government hospital 14
Non-government hospital 18
HMO group/staff model 2
Medical school 31
Solo practice 1
Other 6
ervices Performed by Practice
Outpatient HF program 88
Inpatient HF service 72
Implant MCSDs 47
Perform permanent MCSDs (i.e., destination VADs) 29
Heart transplant program 39
Relate to a heart transplant program and follow transplant
patients
41
hysician Type Caring for Acute HF Patients
Hospitalist 11
Cardiologist 40
HF cardiologist 24
Primary care or other physician type 4
Varies by floor/unit to which patient is admitted 15
Varies by admitting diagnosis 5
ractice Size by Clinical Staff
Small (4) 43
Small-medium (4–10) 34
Medium (11–20) 18
Large (20) 6
HF indicates heart failure; HMO, health maintenance organization; MCSDs, mechanical circula-
tory support devices; and VADs, ventricular assist devices.
Table 3. U.S. Program Volume: Number of Cases
Total
Small Program
(<4 staff)
n107
HF visits per year 366,117 107,926
% of total 29%
Average HF visits per year per program 1,641 1,008
Destination MCSDs implanted per year 868 23
% of total 2%
Heart transplants in 2007 1,991 84
% of total 4%
Heart transplants in 2006 1,938 65
% of total 3%
Heart transplants in 2005 1,832 75
% of total 4%
MCSDs/HF visits per year 1:422 1:4,692
Heart transplants/HF visits in 2007 1:184 1:1,285HF indicates heart failure; and MCSDs, mechanical circulatory support devices.center staff size, indicating that, on average, U.S. HF
practices perform approximately 10 transplants on an annual
basis. It is not surprising that larger programs (with 20
staff) perform significantly more transplants. Nevertheless,
the higher number of small-medium and medium pro-
grams, as defined by staff size, leads to a higher number of
transplants, as shown in Table 3.
Although the data regarding destination MCSD should
be viewed as preliminary because of the developing nature of
this part of the field, it is interesting to note that the
relationship between practice size and number of visits by
patients undergoing destination therapy with MCSD does
not appear to be parallel. Specifically, the average number of
MCSD destination patient visits per year is similar between
medium and large programs (Table 1).
In addition to the care of patients who have undergone
the above surgical procedures, U.S. HF practices reported
an average of 1,641 outpatient HF visits per year for a total
of 366,117 overall visits, as shown in Figure 1 and Table 3.
This average number falls slightly when the international
site data are combined with the U.S. center data; the average
Small-Medium Program
(4–10 staff)
n86
Medium Program
(11–20 staff)
n45
Large Program
(>20 staff)
n14
121,290 99,425 37,476
33% 27% 10%
1,410 2,209 2,676
302 423 120
35% 49% 14%
590 774 543
30% 39% 27%
551 752 570
28% 39% 29%
517 718 522
28% 39% 28%
1:402 1:235 1:312
1:205 1:128 1:69
Figure 1. Distribution of Centers According to the Number of
Heart Failure Visits
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worldwide.
Table 3 depicts the number of HF visits as a ratio to a
single heart transplant or MCSD performed for each
practice size. Although larger programs perform more
transplants than programs with less staff, the higher number
of small-medium and medium programs (as defined by staff
size) leads to a higher volume of transplant cases. Again, we
see that irrespective of the size of the practice, many HF
patients visit the clinics in relationship to the implantation
of a single MCSD. In contrast, larger programs appear to
see fewer HF visits per transplant performed, suggesting
that perhaps larger programs are seeing a more focused
patient population.
6. Staff Description
Table 4 shows the overall number and role of the clinicians
n U.S. HF and transplant programs. In general, the average
umber of FTEs for MDs (2.65), nonphysician practitio-
ers (2.21), and nurse coordinators (2.61) were similar,
eflecting similar ratios of overall providers. Thus, U.S.
enters appeared to hire a core team of physicians, nonphy-
ician practitioners, and nurse coordinators almost in par-
llel numbers. Adding the data from the international sites
hanges the averages slightly, so that the overall staffing was
.54 physician FTEs, 2.49 nonphysician practitioner FTEs,
nd 2.20 nurse coordinator FTEs. A greater percentage of
Table 4. Average U.S. Staffing by Practice Clinician Role
Total
Heart Failure
Program
Transplant
Program
D/DO FTEs 2.65 1.84 1.40
P/PA FTEs 2.21 1.68 1.03
N coordinator FTEs 2.61 1.93 1.32
DO indicates doctor of osteopathy; FTEs, full-time equivalents; MD, medical doctor; NP, nurse
practitioner; PA, physician assistant; and RN, registered nurse.
Table 5. Average U.S. Staffing by Practice Staff Size
Total
Small Program
(<4 staff)
n107
Patient office visits 1,641 1,186.31
MD/DO FTEs 2.65 0.82
NP/PA FTEs 2.21 0.81
RN coordinator FTEs 2.61 0.60
Financial consultant 0.47 0.01
Social worker 0.75 0.17
Exercise physiologist 0.37 0.20
Nutritionist 0.55 0.28
Psychologist 0.45 0.18
Pharmacologist 0.59 0.31DO indicates doctor of osteopathy; FTE, full-time equivalent; MD, medical doctor; NP, nurse practitionepractice FTEs are allocated to HF, with fewer positions
allocated to transplant. Many respondents commented that
it was often difficult to ascribe the physician role to either
HF or transplant work, but the remaining nonphysician
clinicians in most centers tended to focus on either HF or
transplant. Likewise, many physicians are increasingly being
trained to care for MCSDs in addition to transplant, and
our survey may not have accurately captured the number of
physicians who are performing both tasks.
To illustrate the variety of providers utilized in the HF
and transplant programs in the United States, Table 5
shows the types of professionals in programs grouped
according to practice size, as in previous tables. The average
number of outpatient HF visits is shown on the first line as
1 measure of activity for the staff. A very rough approxima-
tion suggests that as 500 to 700 more HF patients are added
to the annual visit schedule, there is a doubling of physician,
nonphysician practitioner, and nurse coordinator FTEs in
the United States. Furthermore, large programs had twice as
many social workers as small programs. Interestingly, the
addition of the international sites did not change this overall
trend. In contrast, the number of FTEs for ancillary support
such as financial consultants, nutritionists, and psychologists
did not increase appreciably as the program’s volume grew.
Thus, large programs, defined by staffing size, perform more
transplants and see more HF outpatient visits but require
twice as many physicians, nonphysician practitioners, and
nurses as medium- and small-sized programs. Nevertheless,
as depicted in Table 6, there is a relatively static percentage
of healthcare professionals across all practice sizes. Programs
grow by the addition of all 3 professionals: a physician, a
nonphysician practitioner, and a nurse.
The survey included a specific question about the staffing
needs for an MCSD program: “Does your MCSD program
involve additional personnel other than what you recorded?”
Half of the U.S. programs, as well as half of the interna-
tional centers, answered affirmatively, reporting a mean of
3.26 additional FTE staff required for centers with MCSD
capabilities.
ll-Medium Program
(4–10 staff)
n86
Medium Program
(11–20 staff)
n45
Large Program
(>20 staff)
n14
1,555.46 2,425.53 3,123.67
2.26 5.41 10.13
2.09 3.78 8.55
2.17 5.39 11.79
0.47 0.78 1.14
0.75 1.03 1.81
0.44 0.42 0.67
0.63 0.71 0.89
0.48 0.67 0.70
0.74 0.70 0.75Smar; PA, physician assistant; and RN, registered nurse.
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The survey also explored the daily responsibilities of the staff
with respect to remote monitoring of HF patients, as shown
in Figure 2. The majority of practices conduct telephone
(82%) or internal cardiac device (75%) monitoring. Fewer
practices monitor electronic home systems, weight, blood
pressure, hemodynamics, or real-time assessment. A large
majority of centers have the capability to perform more than
telephone triage with patients, which is done in80% of all
enters in the United States and internationally. Most
enters are downloading information from implanted car-
iac devices such as defibrillators or biventricular pacemak-
rs. At least half of all responding centers are using an
lectronic home monitoring system that reports data
hrough a telephone or an Internet connection. Figure 3
epicts the frequency of these activities in U.S. centers.
Table 6. Average U.S. Staffing by Practice Size: Role Composit
Total (%)
Small Program
(<4 staff)
n107 (%)
MD/DO FTEs 28.0 29.6
NP/PA FTEs 23.3 29.2
RN coordinator FTEs 27.6 21.4
Financial consultant 3.1 0.2
Social worker 5.2 2.8
Exercise
physiologist
2.2 3.2
utritionist 3.8 5.1
sychologist 2.7 2.8
harmacologist 4.1 5.6
otal no. of staff 2,386 298
DO indicates doctor of osteopathy; FTE, full-time equivalent; MD, medical doctor; NP, nurse pra
Figure 2. U.S. Site-Monitoring ActivitiesBP indicates blood pressure; and HR, heart rate.A full 84% of practices have staff available for monitoring
nticoagulation parameters (e.g., international normalized
atio) and non-device data. Nonphysician practitioners such
s nurse practitioners or clinical nurse specialists are more
ikely to perform this duty. More than half (58%) of the
onphysician practitioners who monitor this type of data
ollow written algorithms to make treatment decisions;
hese percentages did not change substantially when adding
he international center data.
8. Discussion
8.1. General Observations
Acknowledging the increased focus on optimal care of HF
patients in both the inpatient and outpatient arenas, this
staffing survey sought to investigate the number and roles of
all-Medium Program
(4–10 staff)
n86 (%)
Medium Program
(11–20 staff)
n45 (%)
Large Program
(>20 staff)
n14 (%)
25.5 29.4 28.4
23.6 20.6 24.0
24.4 29.3 33.0
3.6 3.9 2.7
6.1 5.4 5.1
2.9 1.8 1.3
4.9 3.3 2.1
3.2 3.0 1.5
5.8 3.3 1.8
762 826 500
r; PA, physician assistant; and RN, registered nurse.ion
Sm
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of 257 unique practices in the United States, and 58
additional international centers, several insights about staff
requirements can be summarized. The majority (77%) of
HF centers is small or small-to-medium practices with 10
total clinical staff members; most of these practices are
within a medical school hospital environment or in a
cardiovascular group setting. More of these sites are per-
forming MCSDs than they are participating in cardiac
transplantation, an observation that has not previously been
appreciated.
The average number of outpatient HF visits per U.S.
heart failure practice is 1,641 patients annually. In addition,
the average practice performs approximately 10 heart trans-
plants/year and between 4 and 5 MCSDs implanted as
destination therapy. These averages do not change appre-
ciably when adding the international data to the American
results. Larger programs perform substantially more heart
transplants on average compared with medium programs,
but the average number of patients referred for MCSD
destination therapy is essentially equivalent. From our data,
it is not possible to know whether surgical procedures
increase first with a subsequent growth of clinical staff in the
larger programs, or that larger programs have the capacity to
undertake the care of more patients following transplanta-
tion or MCSD implantation. The current staffing profile of
the HF program averaged 2.65 physician FTEs, 2.21
nonphysician practitioner FTEs, and 2.61 nurse or nurse
coordinator FTEs annually. Half of the programs reported
an additional 3.25 FTE staff were needed for their MCSD
programs beyond HF and transplant activity. As program
volume increases, there appears to be a relatively fixed ratio
Figure 3. U.S. Site-Monitoring Activities Frequency
BP indicates blood pressure; and HR, heart rate.of staffing roles, so that physicians, nonphysician practitio-ners, and nurses are hired in equivalent numbers to account
for the increased patient activity. A wide range of practice
activities beyond telephone triage is done within most
centers to follow HF patients, with variability in the
frequency of each type of monitoring capability between
practices. Treatment decisions are guided by written algo-
rithms in more than half of practices.
This staffing survey provides an interesting snapshot of
the professionals who are delivering care to our HF patients
and the environment in which they practice. The intensity
of care required by this patient group is underscored by the
fact that at least 6 to 7 clinicians are needed, on average, to
deliver care to 1,641 outpatients with HF, which is roughly
140 patients per month, and 1 new heart transplant
recipient per month. Clearly, all innovations in monitoring
HF patients will need to carefully assess whether staff time
can be utilized more efficiently, or whether monitoring can
be completed independent of personnel interface or done
with personnel other than nurses or nonphysician practitio-
ners. Moreover, with an increased focus on physician
productivity and shorter duration of overall office visits, the
subsequent impact on the number of ancillary professional
personnel to deliver optimal care must be carefully tracked.
From our survey data, it appears that larger volume neces-
sitates both an increased utilization of nurses, as well as an
increased number of all clinicians.
Although only half of the respondents indicated that
additional staffing was required for their MCSD programs,
the average number of FTEs, 3.25, for the MCSD person-
nel is high. Reimbursement models for destination therapy
MCSD will need to account for these supplementary
professionals, placing hospital resources under further
strain. Indeed, we believe this survey only begins to explore
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quality care, with all potential options for care (e.g., trans-
plant, MCSDs, and device monitoring) in a timely manner
to all patients. Moving forward, we hope that individual
centers will analyze in depth their practice requirements for
staff as the types of procedures performed varies, practice
volume changes, or reimbursement models evolve.
8.2. Limitations
These survey results are limited by our inability to ascertain
the validity or the completeness of the data reported.
Practices of large- or small-sized staff may have neglected to
answer the survey; we estimate that about 10% of data from
U.S. transplant centers is missing. Respondents may have
exaggerated their actual staff numbers, their transplant
numbers, or other practice activity. Nevertheless, the re-
spondents indicated a particular enthusiasm for completing
the survey. Almost all supplied additional remarks and
comments where none were required. We believed that we
had unearthed a topic of particular importance to the
professionals who completed the survey, two thirds of
whom were physicians.
9. Conclusions
This joint survey by the ACCF, AHA, and HFSA was
undertaken to determine the current staffing utilization of
HF and transplant programs in the United States and in
international respondents. The majority of HF centers has
small- or small-to-medium–sized staff working within a
cardiovascular group practice or at a medical school hospital
setting. The average practice receives 1,641 outpatient HF
visits, and performs 10 transplants annually. For this clinical
volume, which encompasses a wide variety of patient mon-
itoring activity, 6 FTEs are currently utilized, including,
on average, at least 2 to 3 physicians, 2 nonphysician
practitioners, and 2 nurses. Reimbursement models to
account for these staffing needs must be developed as
healthcare strategies evolve for the HF patient population.
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